The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing

Published:2017-09-19 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Nieuwenhuizen Natalie E.,Kulkarni Prasad S.,Shaligram Umesh,Cotton Mark F.,Rentsch Cyrill A.,Eisele Bernd,Grode Leander,Kaufmann Stefan H. E.

Funder

Seventh Framework Programme

Horizon 2020 Framework Programme

Bill and Melinda Gates Foundation

Bundesministerium für Bildung und Forschung

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference97 articles.

1. In vitro experimental model of trained innate immunity in human primary monocytes;Bekkering;Clin Vaccine Immunol,2016

2. Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges;Aaby;Nat Immunol,2014

3. Non-specific immunological effects of selected routine childhood immunisations: systematic review;Kandasamy;BMJ,2016

4. Disseminated bacille Calmette-Guerin disease after vaccination: case report and review;Talbot;Clin Infect Dis,1997

5. Progress in tuberculosis vaccine development and host-directed therapies – a state of the art review;Kaufmann;Lancet Respir Med,2014

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bactofection, Bacterial-Mediated Vaccination, and Cancer Therapy: Current Applications and Future Perspectives;Vaccines;2024-08-27

2. Epidemiological, cellular, genetic and epigenetic aspects of biosafety;Вестник Российской академии наук;2024-08-15

3. Macrophages directly kill bladder cancer cells through TNF signaling as an early response to BCG therapy;Disease Models & Mechanisms;2024-08-01

4. A broader evaluation of vaccine-induced T cell immunity against tuberculosis;Frontiers in Tuberculosis;2024-07-19

5. Nano-Bacillus Calmette-Guérin immunotherapies for improved bladder cancer treatment;Journal of Zhejiang University-SCIENCE B;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3